FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:1470 April 2, 2009 Number 14

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Burn, J.

Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome . In Table 2 (pages 2572–2573), the third variable should be "Age at recruitment — yr," and the age ranges should read as follows: Aspirin plus Resistant Starch, 25–70; Aspirin plus Placebo, 25–75; Resistant Starch plus Placebo, 25–75; Placebo plus Placebo, 25–78; Aspirin Only, 37–67; Placebo Only, 33–57; Resistant Starch Only, 28–78; and Placebo Only, 36–75. In the first paragraph under Outcomes (page 2573), the data given in the fourth sentence should read, "66 of 350 (18.9%) had one or more neoplastic lesions while receiving aspirin, as . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.